KLRA
Kailera Therapeutics, Inc.
There isn't enough reported data to score KLRA yet.
KLRA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate KLRA's fundamentals.
KLRA PE Valuation
KLRA has no meaningful PE right now: it lost money over the past year.
KLRA Forward outlook
There aren't enough analyst estimates for KLRA to show an outlook.
KLRA Earnings Per Share
KLRA Quarterly Revenue
KLRA Free Cash Flow
KLRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +27% | +27.4M shares |
KLRA Net Leverage
KLRA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KLRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.4 | Oversold |
| Stochastic | 33.4 | Neutral |
KLRA's weekly RSI is 25 (oversold) and its Stochastic is 33 (neutral).
KLRA PE vs Healthcare Sector
KLRA has no meaningful PE right now: it lost money over the past year.
KLRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.0 | 9.7% above |
| 20 week MA | $15.3 | 13% below |
KLRA has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 13% below its 20-week average.
KLRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $26.0 | $13.2 | -49% |
It's down 49% so far in 2026.